|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 23, 2017 ) According to Publisher, the Global Biosurgery Equipment Market is accounted for $16.88 billion in 2015 and is expected to reach $31.25 billion by 2022 growing at a CAGR of 9.2% during the forecast period. Increasing count of surgeries, rise in spine injuries and quick launch of new products are some of the factors fueling the market growth. However, high surgery costs and strict government regulations for approval of products are negatively impacting the market.
For more information http://www.reportsweb.com/biosurgery-equipment-global-market-outlook-2016-2022
North America commanded the market owing to high frequency of surgeries and improved healthcare facilities in the region. The emerging nations in Asia Pacific, Middle East and Africa hold vast potential for growth in the market, due to increased awareness about biosurgery equipment’s among surgeons, rising per capita income along with growing healthcare spending. Entry of various companies into new markets with innovative technologies to increase their market share will enhance the growth of biosurgery equipment market in near future.
Some of the key players in biosurgery equipment market include Sanofi Group, B. Braun Melsungen AG, C. R. Bard, Inc., Hemostasis, LLC, Sanai Ltd., Stryker Corporation, Kuros Biosciences AG, Johnson & Johnson, Covidien PLC, Baxter International Inc., Atrium Medical Corporation, MAQUET Holding B.V. & Co. KG, Integra Life Sciences Corporation, Biom’Up and Cryolife, Inc.
Applications Covered:
- Urology
- Cardiovascular
- Plastic Surgery
- Neurological
- Gynecological
- Orthopedic
- General Surgery
End Users Covered:
- Diagnostic Centers
- Home Care Settings
- Clinics
- Cardiac Catheterization Laboratories
- Hospitals
- Ambulatory Surgical Centers
Product Types Covered:
- Soft Tissue Management
o Tissue Patch/Mesh
- Bone Graft Substitute
o Demineralized Bone Matrix (DBM)
o Synthetic Grafts
o Bone Allografts
o Bone Morphogenetic Proteins (BMP)
- Haemostatic Agents
- Surgical Sealants
o Synthetic Sealants/Cyanoacrylates
o Tissue Adhesives
o Fibrin Sealants
o Collagen-based Compounds
- Staple-line Reinforcement Agents
- Adhesion Barriers
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564968/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
10 Company Profiling
10.1 Sanofi Group
10.2 B. Braun Melsungen AG
10.3 C. R. Bard, Inc.,
10.4 Hemostasis, LLC,
10.5 Sanai Ltd.
10.6 Stryker Corporation
10.7 Kuros Biosciences AG
10.8 Johnson & Johnson
10.9 Covidien PLC
10.10 Baxter International Inc.
10.11 Atrium Medical Corporation
10.12 MAQUET Holding B.V. & Co. KG
10.13 Integra Life Sciences Corporation
10.14 Biom’Up
10.15 Cryolife, Inc.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564968/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
